RIVANNA Awarded $2.9 Million NIH Grant for Expansion of Accuro 3S Indications to Regional Anesthesia in Emergency Medicine RIVANNA Awarded $2.9 Million NIH Grant for Expansion of Accuro 3S Indications to Regional Anesthesia in Emergency Medicine
RIVANNA® expands world-class engineering team to advance development of the Accuro® Product Platform RIVANNA® expands world-class engineering team to advance development of the Accuro® Product Platform
RIVANNA® Announces Partnership with BOMImed to Increase Distribution of Accuro® in Canada RIVANNA® Announces Partnership with BOMImed to Increase Distribution of Accuro® in Canada
Rivanna Announces Record Second-Quarter Accuro Sales Rivanna Announces Record Second-Quarter Accuro Sales
Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia
